# Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer

> **NCT00003977** · PHASE1 · COMPLETED · sponsor: **Steward St. Elizabeth's Medical Center of Boston, Inc.**

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** human papillomavirus 16 E7 peptide
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003977
- **Lead sponsor:** Steward St. Elizabeth's Medical Center of Boston, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003977, "Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00003977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*